The Effectiveness of Surgical Treatment of Patients With Ischemic Cardiomyopathy
Assessment of Risks and Outcomes of Surgical Intervention in Patients With Ischemic Cardiomyopathy in the Early and Long-term Postoperative Period, Selection of Optimal Surgical and Surgical Treatment
1 other identifier
observational
260
1 country
1
Brief Summary
The study focuses on the development of a new personalized approach to diagnostics and surgical treatment of patients with ischemic cardiomyopathy. The algorithm for selection of patients for certain type of cardiac surgery will be developed. The models for prediction of the risks and outcomes of cardiac surgery will be elaborated to reduce the rate of complications in the early and long-term postoperative period in patients with ischemic cardiomyopathy. Imaging modalities, methods for assessement of structural and functional state of the myocardium, biochemistry testing, immunohistochemical examination, and myocardial biopsy studies will be used to achieve these goals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 28, 2013
CompletedFirst Submitted
Initial submission to the registry
July 23, 2020
CompletedFirst Posted
Study publicly available on registry
July 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedJune 26, 2026
June 1, 2026
10 years
July 23, 2020
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of participants with postoperative left ventricular remodeling according to echocardiography.
Number of participants with a decrease in left ventricular end-systolic volume by 15% or more.
12 months
Cardiac death
Cardiac death, %
12 months
Secondary Outcomes (1)
Number of participants with increased exercise tolerance
12 months
Study Arms (4)
CABG
The patients with ischemic cardiomyopathy underwent coronary artery bypass graft (CABG)
CABG with SVR
The patients with ischemic cardiomyopathy underwent coronary artery bypass graft (CABG) with surgical ventricular restoration (SVR)
CABG with mitral repair
The patients with ischemic cardiomyopathy underwent coronary artery bypass graft (CABG) with and mitral repair (MR)
CABG with SVR and mitral repair
The patients with ischemic cardiomyopathy underwent coronary artery bypass graft (CABG) with surgical ventricular restoration (SVR) and mitral repair (MR)
Interventions
Eligibility Criteria
Patients with ischemic cardiomyopathy with indications for cardiac surgery
You may qualify if:
- left ventricular ejection fraction less than or equal to 40%; a history of myocardial infarction with a duration of more than 3 months and/or stenosis of more than 75% of the trunk of the left coronary artery, or proximal stenosis of the anterior descending artery and/or stenosis of more than 75% of two or more coronary arteries; final LV systolic index greater than or equal to 60 ml / m2 according to echocardiography, age 18-70 years
You may not qualify if:
- the presence of organic heart defects of rheumatic and infectious etiology; acute myocardial infarction; less than 3 months after acute coronary or cerebrovascular events; severe pulmonary hypertension not associated with mitral regurgitation (above 75 mmHg); contraindications for operations with cardiopulmonary bypass; chronic alcoholism (including alcoholic damage to the heart), mental disorders; severe course of bronchial asthma, chronic obstructive pulmonary disease in the acute stage; oncological diseases in the terminal stage, refusal of the patient or relatives to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tomsk National Research Medical Center of the Russian Academy of Sciences
Tomsk, 634012, Russia
Biospecimen
Myocardial biopsy: it is planned to intraoperatively collect myocardial biopsy samples from patients with ischemic cardiomyopathy. In case of aneurysmectomy and myocardial biopsy in the middle parts of the left ventricle of the anterior, posterior, lateral walls and interventricular septum on the side of the endocardium, the wall of the aneurysm and the portion of the right atrial appendage, in the absence of an aneurysm, only the portion of the right atrial appendage.
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Vladimir M Shipulin, MD, PhD
Cardiology Research Institute, Tomsk NRMC
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2020
First Posted
July 28, 2020
Study Start
January 28, 2013
Primary Completion
January 28, 2023
Study Completion
May 1, 2024
Last Updated
June 26, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Proposals may be submitted up to 36 months following publication of the results of the trial. After 36 months, the data will be available in the Center's data ware house but without investigator support other than deposited metadata.
- Access Criteria
- Information regarding submitting proposals and accessing data may be requested from the principal investigator by e-mail.
Deidentified individual participant data (text, tables, figures, and appendices), underlying the results of the trial, will be shared with researchers to achieve the aims in the approved proposal.